Finzati - Logo
LMAT logo

LeMaitre Vascular, Inc.

LMATMedical - Instruments & Supplies
$80.67
+0.18 (+0.22%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHLY FAVORABLE PROFILEExcellentConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Strong business quality with supportive growth and cash-flow evidence. Valuation still matters, but the historical ratio profile is favorable.
Market Cap
$1.85B
Growth
8.0%
Cash Flow
5/5
Trend
Stable
Evidence
Stable or improving margins · 23.1%Positive revenue growth · 10.9%Positive free cash flow · 3.29Consistent free cash flow · 5/5Manageable debt level · 0.47
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 7, 2026, 1:01 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$80.67
Change0.22%
Market Cap$1.85B
52W Range78.65 - 118.01
Beta0.52
Gross Margin71.53%
Oper. Margin27.21%
Profit Margin23.13%
Debt/Eq0.47
Current Ratio12.89
Quick Ratio10.95
Revenue 5Y7.96%

Investment DNA

How strong this company looks for long-term investors

85
out of 100
Business Quality
Margins, moat, returns
90/100
Financial Strength
Debt, cash, stability
93/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
48/100
Why this score
Stable or improving margins · 23.1%Positive revenue growth · 10.9%Positive free cash flow · 3.29Consistent free cash flow · 5/5Manageable debt level · 0.47Healthy liquidity · 12.89

Analyst view

Analyst sentiment and price target

Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-08-07
Low
$95.00
Mean
$115.00
Median
$115.00
High
$135.00

Company Overview

IPO: 10/19/2006
Industry: Medical - Instruments & Supplies
P/B i: 4.67
Debt / Equity i: 0.47
Operating Margin: 27.21%
Net Margin: 23.13%
ROE i: -
ROIC: -

Financial Health

Score19 / 20
Debt / Equity: 0.47
Current Ratio: 12.89
Quick Ratio: 10.95
Status: Strong

Insider Transactions

Recent executive and insider activity

LeMaitre George W
Transaction: 06/04/2026
BUY
Change
Price
Not reported
Filing
06/05/2026
Type
BUY
LeMaitre George W
Transaction: 06/04/2026
BUY
Change
+11,974
Price
Not reported
Filing
06/05/2026
Type
BUY
Kamke Trent G
Transaction: 06/04/2026
BUY
Change
Price
Not reported
Filing
06/05/2026
Type
BUY